We are live on ! Find out more
Whitebox Advisors

Whitebox Advisors Portfolio holdings

AUM $7.65B Turnover 32.48%
1-Year Est. Return 13.87%
 

Whitebox Advisors is a multi-strategy hedge fund manager founded in 1999. It invests across asset classes and markets for institutions, private entities and qualified individuals. Its trades include convertible arbitrage, distressed credit and municipal bonds. Robert Vogel, a partner and the firm's chief investment officer, is its majority owner.

This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+13.87%
3 Year Est. Return
+24.22%
5 Year Est. Return
+33.25%
10 Year Est. Return
+180.55%
AUM
$7.65B
AUM Growth
-$592M
Cap. Flow
-$3.5B
Cap. Flow %
-45.77%
Top 10 Hldgs %
31.69%
Holding
745
New
163
Increased
24
Reduced
37
Closed
79
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.5 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.51%
2 Financials 9.04%
3 Healthcare 5.77%
4 Industrials 2.04%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FTRA.U
101
FutureCorp Space Acquisition 1 Units
FTRA.U
$4.05M 0.05%
+400,000
New +$4.06M
2026 Q2
0 quarters
GUACU icon
102
Berto Acquisition Corp II Unit
GUACU
$4.05M 0.05%
+400,000
New +$4.03M
2026 Q2
0 quarters
EMIS icon
103
Emmis Acquisition Corp
EMIS
$164M
$4.04M 0.05%
400,000
– –
2025 Q4
2 quarters
MMTX icon
104
Miluna Acquisition Corp
MMTX
$90.8M
$4.04M 0.05%
400,000
– –
2026 Q1
1 quarter
OTAI.U
105
Starlink AI Acquisition Corp Units
OTAI.U
$4.04M 0.05%
+400,000
New +$4.03M
2026 Q2
0 quarters
ATLQU
106
JAB Acquisition Corp I Unit
ATLQU
$4.01M 0.05%
+400,000
New +$4.01M
2026 Q2
0 quarters
ALPXU
107
Alpex Acquisition Corp Unit
ALPXU
$4.01M 0.05%
+400,000
New +$4M
2026 Q2
0 quarters
ETSS.U
108
Energy Transition Special Opportunities Units
ETSS.U
$4M 0.05%
+400,000
New +$4M
2026 Q2
0 quarters
PTACU icon
109
Patriot Acquisition Corp Units
PTACU
$4M 0.05%
+400,000
New +$3.99M
2026 Q2
0 quarters
NTWO icon
110
Newbury Street II Acquisition Corp
NTWO
$109M
$3.99M 0.05%
375,000
– –
2025 Q2
4 quarters
AACP icon
111
Apogee Acquisition Corp
AACP
$3.98M 0.05%
+400,000
New +$3.99M
2026 Q2
0 quarters
WLCOU
112
Wilco 63 Corporation Units
WLCOU
$3.98M 0.05%
+400,000
New +$3.98M
2026 Q2
0 quarters
ALOV icon
113
Aldabra 4 Liquidity Opportunity Vehicle
ALOV
$376M
$3.98M 0.05%
400,000
– –
2026 Q1
1 quarter
VECA icon
114
Vernal Capital Acquisition Corp
VECA
$130M
$3.98M 0.05%
+400,000
New +$3.98M
2026 Q2
0 quarters
FGII icon
115
FG Imperii Acquisition Corp
FGII
$292M
$3.97M 0.05%
+400,000
New +$3.97M
2026 Q2
0 quarters
PTOR icon
116
Praetorian Acquisition Corp
PTOR
$338M
$3.97M 0.05%
+400,000
New +$3.95M
2026 Q2
0 quarters
MLAA icon
117
Mountain Lake Acquisition Corp II
MLAA
$3.97M 0.05%
400,000
– –
2026 Q1
1 quarter
QLEP
118
Quantum Leap Acquisition Corp
QLEP
$301M
$3.97M 0.05%
+400,000
New +$3.98M
2026 Q2
0 quarters
SORN icon
119
Soren Acquisition Corp
SORN
$351M
$3.97M 0.05%
400,000
– –
2026 Q1
1 quarter
IPVVU icon
120
InterPrivate Investment Partners V Units
IPVVU
$3.97M 0.05%
+400,000
New +$3.97M
2026 Q2
0 quarters
CAQ icon
121
Cambridge Acquisition Corp
CAQ
$313M
$3.96M 0.05%
+400,000
New +$3.95M
2026 Q2
0 quarters
BREZ
122
Breeze Acquisition Corp II
BREZ
$199M
$3.96M 0.05%
+400,000
New +$3.97M
2026 Q2
0 quarters
GSRVU icon
123
GSR V Acquisition Corp. Units
GSRVU
$3.9M 0.05%
+390,000
New +$3.9M
2026 Q2
0 quarters
SRPT icon
124
PUT
Sarepta Therapeutics
SRPT
$1.85B
$3.86M 0.05%
214,600
– –
2025 Q2
4 quarters
RFAM icon
125
RF Acquisition Corp III
RFAM
$139M
$3.83M 0.05%
+387,000
New +$3.82M
2026 Q2
0 quarters

Similar funds

Whitebox Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Whitebox Advisors held 745 positions worth $7.65B, down 7.2% from $8.24B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Whitebox Advisors withdrew a net $3.5B in Q2 2026, closing 79 positions and reducing 37 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $52.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 81% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Whitebox Advisors opened a new position in Bio-Techne worth $148M.

  • Whitebox Advisors's largest Q2 2026 buy was Bio-Techne: 2,100,001 shares worth $148M.
  • Whitebox Advisors added most to Caesars Entertainment in Q2 2026, an estimated $92.1M increase.
  • Whitebox Advisors's biggest Q2 2026 reduction was Chart Industries, cutting an estimated $137M.
  • Whitebox Advisors fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $52.7M.
  • Whitebox Advisors's ten largest holdings make up 32% of its $7.65B portfolio in Q2 2026.
  • Whitebox Advisors opened 163 new positions and closed 79 in Q2 2026.
  • Whitebox Advisors's portfolio value fell 7.2% quarter-over-quarter to $7.65B.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.